MAPK3 and breast carcinoma: Similar effects by CAP1 knockdown on ERK1/2 phosphorylation have been demonstrated in the breast cancer cell lines BT-549 and MDA-MB-231 previously, however this resulted in increased proliferation which is in contrast to our results (32).